DXR
Daxor CorporationNASDAQ
Healthcare • Medical Instruments & Supplies
Updated 1 day ago
Coverage ready
Factor tilt: Value-tilted Micro Cap
$10.35+0.45%
Close Oct 13, 2026
- Market cap
- $51.6M
- 1 month
- -8.1%
- 3 months
- -1.4%
- 1 year
- -11.8%
- 52-week range
- $8.87$14.75
- Dividend, last 12 mo
- None in the last year
- Last ex-date
- Jan 5, 2018 · $0.03
- Short interest
- 0.2% of float7K shares · settled Sep 30, 2026 · +198.5% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if DXR is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
2 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 3
Largest 13-F holders · Q2 2026
15 filers reported a long position in DXR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| THOMPSON SIEGEL & WALMSLEY LLC | $2.5M | 241.8K | +4.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $495.6K | 48.8K | +1.1% |
| Aristides Capital LLC | $429.2K | 41.7K | 0% |
| RENAISSANCE TECHNOLOGIES LLC | $302.9K | 29.4K | +5% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $275.4K | 27.1K | +97.7% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $128.7K | 12.5K | Unchanged |
| Crescent Grove Advisors, LLC | $127.9K | 12.4K | +15.9% |
| SBI Securities Co., Ltd. | $32.2K | 3.1K | +0.1% |
| MORGAN STANLEY | $31.8K | 3.1K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $10.5K | 1K | Unchanged |
Get the Full Analysis for DXR
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.